Abstract

B type natriuretic peptide (BNP) and its precursor, the inactive form of NT-pro-BNP, are currently the most studied laboratory parameters in the heart disease spectrum. The assessment of their blood concentrations provides invaluable information on the likelihood, severity and prognosis of the disease. The present review aims to describe the biological determinants, the factors that influence these peptide concentrations, the suggested cutoff values for the diagnosis of heart failure and the use of this biomarker in the assessment of cardiac function.

Highlights

  • The natriuretic peptide family consists of atrial natriuretic factor (ANF), brain natriuretic peptide, called type B (BNP), and C-type natriuretic peptide (CNP)

  • The messenger ribonucleic acid of the atrial natriuretic factor has been found in many tissues, it is abundant in the cardiac atria

  • In response to distension of the atrial tissue, there is an increase in ANF and B type natriuretic peptide (BNP) plasma concentrations, which antagonize the effects of angiotensin II in vascular tone, aldosterone secretion, sodium reabsorption and vascular cell growth

Read more

Summary

Peptídeo natriurético tipo B na avaliação da função cardíaca

Adriana Polachini do Valle; Paulo José Fortes Villas Boas; Edison Iglesias de Oliveira Vidal; Fernanda Bono Fukushima abstract. B type natriuretic peptide (BNP) and its precursor, the inactive form of NT-pro-BNP, are currently the most studied laboratory parameters in the heart disease spectrum. The assessment of their blood concentrations provides invaluable information on the likelihood, severity and prognosis of the disease. The present review aims to describe the biological determinants, the factors that influence these peptide concentrations, the suggested cutoff values for the diagnosis of heart failure and the use of this biomarker in the assessment of cardiac function

Introduction
Biological determinants of BNP concentrations
Comorbidities that influence the interpretation of BNP concentrations
Cardiac atrium
BNP in the assessment of cardiac function
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.